Pharmaceuticals

Politics John Wilkerson

STAT Plus: Republicans consider a new attack on Biden ‘march-in’ plan for lower drug prices

The Readout Damian Garde

STAT Plus: Where’s Lilly’s Alzheimer’s approval?

Pharma Andrew Joseph

STAT Plus: Novo Nordisk’s diabetes drug Ozempic cuts risk of kidney disease progression, trial shows

Health Associated Press

First over-the-counter birth control pill in U.S. begins shipping to stores

Biotech Jason Laughlin — Boston Globe

STAT Plus: ‘It’s a nightmare’: One of the most common children’s asthma meds is no longer available, leaving families scrambling

Politics Rachel Cohrs

STAT Plus: White House touts incremental step in Medicare drug price negotiation: counteroffers

Biotech Robert Weisman — Boston Globe

STAT Plus: Massachusetts lawmakers consider $1 billion proposal to bolster region’s life science leadership

The Readout Meghana Keshavan

STAT Plus: Serum Institute of India wants government HPV contract

Health Associated Press

CVS and Walgreens plan to start dispensing abortion pill mifepristone soon

Pharmalot Ed Silverman

STAT Plus: Many costly generic drugs are unavailable at Amazon, Cuban, and other alternative pharmacies

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

The Readout Meghana Keshavan

STAT Plus: Despite good data, Ironwood’s shares plummet 

Biotech Matthew Herper

STAT Plus: Here are the cancer drugs Pfizer thinks could reignite investors’ interest

D.C. Diagnosis Rachel Cohrs

House looks to weaken Medicare negotiation

The Readout Damian Garde

STAT Plus: The next act for a biotech rainmaker

Biotech Allison DeAngelis

STAT Plus: Q&A: A biotech VC leader shares her next big bets

Pharma Matthew Herper

STAT Plus: Pfizer is about to make a big push in cancer. Will investors listen?

Exclusive Ed Silverman

STAT Plus: White House to hold a listening session on reforming pharmacy benefit managers

The Readout Damian Garde

STAT Plus: Beam is trading like it’s 2021

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more

The Readout Meghana Keshavan

STAT Plus: GSK pill works in uncomplicated gonorrhea

Health Olivia Goldhill

STAT Plus: FDA protocols originally intended to be extra conservative are now heralded as evidence of mifepristone’s risk

The Readout Damian Garde

STAT Plus: The FDA isn’t afraid to yank a disappointing drug

Pharma Andrew Joseph

STAT Plus: Obesity treatment from Boehringer Ingelheim, Zealand Pharma succeeds in study in liver condition MASH

Pharmalot Ed Silverman

STAT Plus: Oregon suspends a portion of its drug transparency law found to be unconstitutional

Pharmalot Rachel Cohrs and Ed Silverman

STAT Plus: Amgen’s rheumatoid arthritis drug Enbrel targeted for first-in-the-nation price limit in Colorado

Health tech Bob Herman, Brittany Trang, and Tara Bannow

STAT Plus: UnitedHealth cyberattack impedes pharmacies’ and hospitals’ ability to process insurance claims

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

The Readout Meghana Keshavan

STAT Plus: What do CEOs owe the world?